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Carbamazepine is an antiepileptic drug which is considered one of the persistent compounds 
detected in Malaysian aquatic environment. In this present study, a full factorial experimental design 
was applied for the analysis of effect NaCl amount, initial concentration of carbamazepine, applied 
voltage and treatment time on the electrochemical removal percentage of carbamazepine. However, 
applied voltage was found as the most significant factor with p = 0.00 lower than 95% confidence 
level. The investigation of effect NaCl and Na2SO4 on the pathway degradation for carbamazepine 
was provided using liquid chromatography-time of flight/mass spectrometry (LC-TOF/MS). The 
results showed that new by-products were identified such chloro-epoxy carbamazepine, and other 
by-products, were detected in the presence of NaCl and Na2SO4 electrolytes. High inhibition 
percentage of Escherichia coli (E. coli) bacteria was observed at 24.0 h incubation time for both 
NaCl and Na2SO4 electrolytes after 80 and 20 min of treatment, respectively. 
Keywords: electrochemical removal, full factorial experimental design, NaCl and Na2SO4 as 
supporting electrolytes, by-product elucidation, toxicity evaluation
Introduction
The occurrence of some emerging compounds like 
pharmaceuticals in water samples has been considered as 
one of the emerging issue in environment chemistry. The 
widespread presence of pharmaceuticals in the aquatic 
environment could be attributed to their extensive use in 
medical practice and incomplete removal in wastewater 
treatment plants (WWTPs).1-5 One of these emerging 
compounds is carbamazepine (CBZ) (C15H12N2O), which 
is one of the most widely used antiepileptic drugs. 
According to many previous studies, carbamazepine 
is considered one of the most resistant compound for 
both conventional and advanced wastewater treatment 
process. Consequently, CBZ was widely detected in 
influent and effluent of sewage treatment plant (STP), 
as well as in surface water due to its persistence for 
degradation.6-10 
Carbamazepine has been treated by different treatment 
technologies such as ultrasonication, Fenton’s oxidation 
and ferro-sonication,11 biodegradation after advanced 
oxidation process (UV/H2O2),8 addition of aqueous chlorine 
directly to carbamazepine solution12 and addition of 
some oxidizing agent directly into solution such as MnVII 
and FeVI.13 However, most of these processes have some 
disadvantages, for instance, UV-light source is harmful to 
skin and eyes, adding raw materials and/or chlorine solution 
directly to the solution is also considered risky for the 
health. Electrochemical oxidation process is widely applied 
to degrade the organic pollutants as reported in previous 
studies.14-17 An important advantage of electrochemical 
oxidation is the ability to degrade the organic pollutants 
completely to CO2 and water.18 
In electrochemical oxidation process, the electrolyte has 
Full Factorial Experimental Design for Carbamazepine Removal Using Electrochemical Process J. Braz. Chem. Soc.1722
an important role to generate the oxidizing agent which is 
responsible for degradation of organic pollutants.
The main oxidizing agents in solution are hydroxyl 
radicals, OCl−/HOCl and S2O82− in which the generation of 
these oxidizing agents depend on the type of electrolyte. 
The hydroxyl radicals are generated after electrochemical 
oxidation of water at the surface of anode which is a very 
powerful oxidant and it seems to be directly involved in 
the oxidation mechanisms that occur on the surface of 
electrode.19-23 Mussa et al.24 have been using NaCl to generate 
OCl−/HOCl electrochemically which is strong oxidizing 
agent used to treat leachate sample and simvastatin. Some 
other authors used Na2SO4 as supporting electrolyte to 
produce weaker oxidizing agent (peroxodisulfate, S2O82−) 
which is used to treat carbamazepine by electrochemical 
advanced oxidation process16 as shown in equations 1-5:
2Cl– → Cl2 + 2e– (1)
Cl2 + H2O → H+ + Cl– + HOCl (2)
HOCl ↔ H+ + OCl– (3)
OCl–/HOCl + organic pollutant → CO2 + H2O + Cl– (4)
2SO42– → S2O82– + 2e– (5)
Up to now, many studies reported the degradation of 
carbamazepine or other organic pollutants by varying 
oxidation ways, but the main question is what are the 
by-products formed and how to identify these compounds 
at different electrolytes. However, most of the by-products 
formed during the photodegradation process are hydroxyl-
derivatives of carbamazepine since OH• is the most radical 
available in the solution after photo oxidation of water. 
Moreover, some chlorinated by-products of carbamazepine 
were observed using aqueous chlorine as direct oxidation.12 
In electrochemical oxidation process, the formation of 
by-products depends on the type of electrolyte in the 
solution. Brillas et al.19 used boron doped diamond (BDD) 
electrode with Na2SO4 electrolyte for the treatment of 
diclofenac, however, the main by-products are derivatives 
of hydroxyl-diclofenac. Mussa et al.14 used graphite-
polyvinylchloride (PVC) as anode with NaCl as supporting 
electrolyte to treat caffeine; they noticed that the main 
by-products are chlorinated compounds. In the light of this 
comparative study, the type of electrolyte is so important 
to determine the pathway of by-product formation during 
electrochemical oxidation process.
In Malaysia, carbamazepine was detected frequently 
in water samples; influent and effluent of wastewater, and 
surface water, this is attributed to incomplete removal of 
carbamazepine in wastewater treatment. However, the 
chemical oxidation and biological treatment processes 
are not effective for this purpose. Therefore, the objective 
of this present work is to apply an effective and clean 
treatment process which is electrochemical treatment 
using graphite as anode for the removal of carbamazepine. 
The study aims to analyze the influence of the different 
operating variables on the carbamazepine removal, and 
to find out the optimum values for this electrochemical 
treatment process. In addition, this work has also the 
purpose to analyze and identify the main chlorinated 
and non-chlorinated by-products in the presence of 
NaCl and Na2SO4 as supporting electrolytes using 
liquid chromatography-time of flight/mass spectrometry 
(LC-TOF/MS) instrument. The most effective parameter 
for CBZ removal was defined by using full factorial design 
method. Finally, the further gain insights by using NaCl 
and Na2SO4 in electrochemical oxidation process, the 
generation of by-products and evaluation of its toxicity 
were also tested after their exposure to the Escherichia coli 
(E. coli) bacteria at different incubation time.
Experimental
Reagents
Sodium chloride (NaCl) and sodium sulfate 
(Na2SO4) used as supporting electrolyte were purchased 
from Merck (Germany) with purities of more than 
99.5%. Tetrahydrofuran (THF) (CAS No. 109-99-9), 
polyvinylchloride (PVC) were purchased from Sigma-
Aldrich (USA). Carbamazepine (CBZ) (CAS No. 298-46-4) 
were obtained from Sigma-Aldrich (USA). The deionized 
water (DI) used was supplied by EASYPure RODI 
(USA). HPLC-grade acetonitrile (ACN), HPLC grade 
acetone, HPLC grade methanol and formic acid (FA) were 
supplied by Merck (Germany). For toxicity experiments, 
Escherichia coli (E. coli) bacteria was obtained from 
Laboratory of Microbiology, Faculty of Sciences and 
Technology, University Kebangsaan Malaysia, Bangi, 
Malaysia and Mueller Hinton broth (nutrient broth) was 
obtained from Merck (Germany). 
 
Experimental procedures
The reaction was provided using a Pyrex glass vessel 
(100 mL). The Pyrex glass electrochemical cell (reactor) 
was placed on a magnetic stirring block to keep its contents 
well mixed during the experiment. Graphite-PVC pellet 
and Pt plate were used as anode and cathode, respectively. 
The distance between the electrodes was approximately 
2.5 cm. The electrodes were then connected to a direct 
current (DC) power supply (CPX200 DUAL, 35 V, 10 A, 
PSU, AIM-TTI, UK). 
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The experimental design and setup of the graphite-
PVC composite electrode was presented (see Figure S1, 
Supplementary Information (SI) section).
The Pt metal foil electrode was prepared by using a 
Pt metal foil (99.98% purity from Aldrich Chemical Co., 
USA). A 0.5 mm-thick Pt foil was cut into approximately 
1 × 1 cm piece. The Pt foil was then connected to a silver 
wire with silver conducting paint and then sealed to a glass 
rod. Subsequently, epoxy gum was applied to cover the 
silver wire connecting surface.
The graphite-PVC electrode was prepared by mixing 
a weighed portion of graphite powder (100 mesh in size 
and 99.9% purity from Aldrich Chemical Co., USA) 
and PVC in 4 mL tetrahydrofuran solvent. The graphite-
PVC electrode was then swirled flatly to homogeneous 
consistency followed by drying in an oven at 50 °C for 
3 h. The mixture was placed in 1 cm diameter stainless 
steel mold and pressed at 10 ton cm-2 by using hydraulic 
machine. A typical pellet contained approximately 95% 
of graphite and 5% of PVC. The total weight of the pellet 
was approximately 1.5 g. The graphite-PVC pellet was 
connected to a silver wire using silver conducting paint 
and sealed to a glass rode. Subsequently, epoxy gum was 
applied to cover the silver wire connecting surface.
Analytical methods
The evaluation of removal percentage of CBZ in the solution 
after electrochemical oxidation process was performed by 
high performance liquid chromatography (HPLC), from 
a Waters Chromatograph (Milford-MA, USA). HPLC is 
equipped with a PerkinElmer 785 A UV-Vis detector and 
a chromolith Rp-18e, C18 column (5 μm, 100 × 4.8 mm). 
The monitoring CBZ after treatment was performed in a 
gradient mode with 0.1% formic acid (FA) in DI water as 
mobile phase A and methanol as mobile phase B, at flow 
rate of 0.9 mL min-1 and a column temperature of 22-25 °C. 
Each run started with an initial mobile-phase composition of 
0% B and was then linearly increased to 100% B over 4 min 
and then kept isocratic for 1 min. The volume of injection 
was 20 μL in all experiments. Detection of CBZ was made 
at 283 nm wavelength. The retention time of CBZ was 
2.76 min and the total run was 5 min. The treated solutions 
were withdrawn after 10 and 40 min then filtered using 
0.45 μm filter syringe before injection by HPLC, which is 
used to monitor the removal% of carbamazepine.
For monitoring the by-products of carbamazepine, 
LC-TOF/MS instrument was used for this purpose. The 
treated solutions, withdrawn every 20 min for 160 min. 
Samples from the degradation experiments were 
separated on a Dionex Ultimate 3000/LC 09115047 
(USA) system. The chromatographic separation was 
performed on a Thermo Scientific C18 (250 × 2.1 mm, 
i.d. 5 μm) column. The injection volume was 30 μL. CBZ 
and its by-products were analyzed in positive ion (PI) 
mode (negative mode gives very poor fragmentation). 
Carbamazepine and its by-products were eluted off the 
column with a mobile phase consisting of (A) 0.1% 
formic acid in DI water and (B) ACN-MeOH (3:1, v/v) 
at 0.3 mL min-1. The elution started at 5% B and was 
then linearly increased to 60% B over 3 min, further 
increased to 97% B over 3 min, and then kept isocratic 
for 5 min. Next, the elution was returned to its starting 
conditions over 11.1 min and allowed to equilibrate for 
5 min prior to the next run. The mass spectrometry was 
carried out on a TOF instrument (Bruker, Germany) 
equipped with a Z-spray electrospray interface. The results 
were obtained with the following settings: MS capillary 
voltages, 4000 (PI); collision energy for diclofenac, 10 eV; 
drying-gas flow rate, 8.0 L min-1; drying gas temperature, 
190 °C; set capillary, 4000 V; set end plate offset −500 V; set 
collision cell RF, 250 Vpp and nebuliser pressure, 4.0 bar. 
The TOF results were collected between m/z 50-600. All 
analytes were acquired using an independent reference 
spray via the LockSpray interference to ensure accuracy and 
reproducibility; mixture of sodium hydroxide and formic 
acid was used as the lock mass m/z 90.9766-974.8132. 
The accurate mass was calculated using software Daltonic 
Analysis incorporated in the instrument. 
Toxicity test
In addition to analysis and identification of the 
by-products, a toxicity test was also performed for 
CBZ and its by-products. For this purpose, samples 
were collected after different times of treatment (0, 20, 
40, 60, 80, 100, 120, 140 and 160 min). The response 
of the toxicity is the inhibition percentage (I%) of the 
bioluminescence of the bacterium E. coli (equation 6) 
which was determined by Hach spectrophotometer 
instrument (model DR 2400). 
The effect of incubation time (i.e., exposure time to the 
bacteria) on the inhibition of bacteria was investigated at 
1.0, 5.0 and 24.0 h.
 (6)
where I% is the percentage of inhibition; Abss is the 
absorbance of sample after different electrochemical 
degradation treatment times; Absc is the absorbance of 
control sample.
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Full factorial design of experiments
This experimental design, which examines NaCl 
amount (g), initial concentration of CBZ (mg L-1), applied 
voltage (V) and treatment time (min) factors at once, has 
been used widely instead of conventional experimental 
design, which investigates every variable by changing one 
by one. The experiments require several factors where it is 
necessary to study the interaction effect of factors on the 
response (R%).25 2n factorial design of experiments needs 
less number of experiments for several factors; thus, less 
cost and time are required.26,27
Factorial design states that which factor influences 
the variation of one factor on the other factors.25 The four 
factors were varied at two levels (+1, −1) as shown in 
Table 1, to investigate their effects on CBZ removal.
Experiments for full factorial design were conducted 
in a 50 mL solution of CBZ. Solutions were always 
kept between 20 and 22 °C, which was the maximum 
temperature that can be used in the cell without significant 
water evaporation during prolonged electrolysis. 
A magnetic bar (400 rpm) was used to ensure mixing 
and to the transport of reactions toward/from the electrodes. 
However, aliquots of the solutions were withdrawn from 
the reactor and filtered using 0.45 μm filter syringe, then 
analyzed either using HPLC or LC-TOF/MS as described 
in the Results and Discussion section.
Results and Discussion
Full factorial design of experiments
The electrochemical degradation of carbamazepine 
usually depends on some factors such as NaCl amount, 
initial concentration of CBZ, applied voltage and treatment 
time. The results of the experimental design were analyzed 
using MINITAB 17 statistical software28 to evaluate the 
statistical parameters and the statistical plots (Normal 
probability, Pareto of the standardized effects, main effects, 
and interactions plots). Forty-eight experiments were 
tested for CBZ electrochemical degradation using 24 full 
factorial design and three replications of each experiment. 
The matrix was established according to their high and 
low levels, represented by +1 and −1, respectively. The 
coded values of variables with the responses (percentage 
of removal efficiency) were illustrated in Table 2. 
The main effects of CBZ removal were identified based 
on the p value with > 95% of confidence level. The codified 
equation 7 was used to explain the 24 factorial designs of 
CBZ removal by electrochemical degradation:
Y = X0 – X1A – X2B – X3C – X4D + X5AB + X6AC + 
X7AD + X8BC + X9BD + X10CD – X11ABC –  
X12ABD + X13ACD – X14BCD + X15ABCD (7)
where Y is the predicted response (removal efficiency in 
percentage), X0 represents the global mean, Xi is the 
regression coefficient corresponding to the main factor 
effects and interactions, A is the NaCl amount (g), B is 
the initial concentration of CBZ (mg L-1), C is the applied 
voltage (V), and D is the treatment time (min). 
The main and interaction effects, coefficients of the 
model, standard deviation of each coefficient, regression 
coefficients, standard errors, and t and p values were shown 
in Table 3.
All the main factors (NaCl amount, initial concentration 
of CBZ, applied voltage and treatment time) and their 
interactions were significant at a 5% of probability level 
(p < 0.05). When the factor effect is negative, removal 
efficiency decreases as the factor is changed from low 
to high levels (as seen from initial concentration CBZ). 
In contrast, if the effects are positive, removal efficiency 
increases to high level of the same factor (as seen from 
NaCl, applied voltage and treatment time). Furthermore, 
the fit models, submitted square correlation coefficient 
(R2) of 0.9999, were in good agreement with the statistical 
model.
Figure 1a shows the main effects of the four factors 
(A, B, C and D) on removal efficiency (%) for CBZ. The 
effect of a factor is the change in response produced by 
the change in level of factor. This is frequently called a 
main effect as it refers to the primary factor of interest 
in the experiment.29 It was concluded that the larger the 
vertical line is the larger the change in removal efficiency 
(%) when it is changing from level −1 to +1. The model 
equation related to the level of parameters and removal 
efficiency was obtained by substituting the regression 
coefficients in equation 8:
Y = 24.69 − 263.6A − 3.053B − 7.420C − 1.7113D + 
23.013AB + 82.26AC  + 1.189AD + 0.9476BC + 
0.23025BD + 0.4436CD − 7.278ABC − 1.2022ABD + 
0.7601ACD − 0.067378BCD + 0.33427ABCD (8)
Table 1. High and low levels for all four parameters
Factor Low level (−1) High level (+1)
NaCl amount / g 0.1 0.2
Initial concentration CBZ / (mg L-1) 5 20
Applied voltage / V 3 6
Treatment time / min 10 40
CBZ: carbamazepine.
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Table 2. Design matrix for carbamazepine removal
Run NaCl amount (A) / g Initial concentration ofCBZ (B) / (mg L-1) Applied voltage (C) / V
Treatment 
time (D) / min
Removal 
efficiency (Y) / %
1 +1 +1 +1 +1 70.00
2 −1 +1 +1 +1 0.58
3 −1 −1 +1 +1 48.40
4 −1 −1 −1 +1 0.57
5 −1 −1 −1 −1 0.33
6 +1 −1 +1 +1 97.39
7 +1 −1 −1 +1 9.10
8 +1 −1 −1 −1 1.43
9 +1 +1 −1 +1 2.55
10 +1 +1 −1 −1 0.36
11 −1 +1 −1 +1 4.21
12 −1 +1 +1 −1 11.97
13 +1 −1 +1 −1 40.21
14 +1 +1 +1 −1 14.65
15 −1 −1 +1 −1 16.52
16 −1 +1 −1 −1 0.22
Mean of three replications; CBZ: carbamazepine.
Table 3. Statistical parameters for 24 design
Term Effect Coefficient Standard error 
coefficient t p
Constant 19.9308 0.0532 374.40 0.00
A 19.4450 9.7225 0.0532 182.64 0.00
B –14.1042 –7.0521 0.0532 –132.47 0.00
C 35.0133 17.5067 0.0532 328.87 0.00
D 18.9167 9.4583 0.0532 177.68 0.00
AB –1.6392 –0.8196 0.0532 –15.40 0.00
AC 17.2133 8.6067 0.0532 161.68 0.00
AD 12.5767 6.2883 0.0532 118.13 0.00
BC –12.9375 –6.4688 0.0532 –121.52 0.00
BD –6.2208 –3.1104 0.0532 –58.43 0.00
CD 15.3950 7.6975 0.0532 144.60 0.00
ABC 1.2142 0.6071 0.0532 11.40 0.00
ABD 3.3975 1.6988 0.0532 31.91 0.00
ACD 11.1117 5.5558 0.0532 104.37 0.00
BCD –5.8175 –2.9088 0.0532 –54.64 0.00
ABCD 5.6408 2.8204 0.0532 52.98 0.00
S 0.368813
R-Sq 99.99%
R-Sq (adj) 99.98%
A: NaCl amount; B: initial concentration of CBZ; C: applied voltage; D: treatment time; S: standard deviation; R-Sq: R2 (coefficient of determination).
Equation 8 indicated that all variable interactions were 
significant, thus, it could not be ignored from the model. 
Figure 1b showed that the effect of NaCl amount on 
removal efficiency (%) was more noticeable when the 
applied voltage and treatment time were high, but at lower 
applied voltage and treatment time, effect of NaCl amount 
was not so high. On the contrary, applied voltage effect 
was high at lower initial concentration CBZ and long 
treatment time.
Figure 2a shows the normal probability plot of 
the standardized effects with p = 0.05 to evaluate the 
significance of each factor and its interactions on removal 
efficiency (%). Normal probability plot could be separated 
into two regions, right and left. Right region includes 
positive coefficients (from C to ABC) while left region 
includes negative coefficients (AB, BCD, BD, BC and 
B). The factors symbolized as square are considered 
significant. Relative importance of the individual and 
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interaction effects was given by the Pareto chart of the 
standardized effects in Figure 2b. In order to identify 
whether the calculated effects were significantly different 
from zero, Student’s t-test was performed and the 
horizontal columns in Pareto chart showed the values for 
each effect. The minimum statistically significant effect 
magnitude for 95% confidence level is represented by the 
vertical line in the chart (2.0).
All values higher than 2.0 (p = 0.05), dashed line’s 
right side, are significant. An increase of applied voltage, 
NaCl amount and treatment time resulted in an uptrend in 
the percentage removal of CBZ, because the increasing 
of these factors produces an enough amount of OCl− as 
oxidizing agent which participates directly to increase the 
removal of CBZ. The interaction of two factors AC gives 
positive indication on removal efficiency of CBZ; thus, an 
increase in applied voltage and increasing of NaCl amount 
together resulted in an increase in removal efficiency (%). 
This antagonistic effect would not be distinguished in the 
univariate optimization of the CBZ removal process.
Characterization of the by-products
The identification of various emerging compounds 
and their by-products was reported widely in literature. 
However, a few studies have been found about the 
Figure 1. Plots of (a) main effects and (b) interaction effects for the removal efficiency (%) for carbamazepine.
Figure 2. (a) Normal probability plot of the standardized effects at 
p = 0.05; (b) Pareto chart of standardized effects on the removal efficiency 
(%) for carbamazepine.
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electrochemical oxidation of carbamazepine.11,16 The 
analysis and identification of the by-products were 
achieved using liquid chromatography-time of flight/
mass spectrometry. All mass peaks of the by-products 
were extracted at 0.02 Da narrow window using Bruker 
DaltonicAnalysis software. LC-TOF/MS chromatograms of 
CBZ after 20-40 min electrochemical oxidation treatment 
in the presence of NaCl and Na2SO4 were presented in 
Figures 3a and 3b, respectively. It was observed that six 
main by-products were formed in the presence of NaCl 
whereas three by-products were produced in the presence 
of Na2SO4 electrolytes.
The nine by-products were separated and identified 
according to their retention times (tR) and m/z ratio as 
follow: product I and VIII at tR = 7.72 min, product II at 
tR = 8.21 min, product III at tR = 8.98 min, product IV at 
tR = 9.11 min, product V at tR = 10.48 min, product VI at 
tR = 11.01 min, product VII at tR = 5.67 min and product 
IX at tR = 9.15 min.
A fully understanding of the formation and mechanism 
pathway of the by-products are presented in Scheme 1 and 
Figure 4. However, sodium adduct molecular ion [M + Na]+ 
is the dominant ion in all compounds. Products I-IX were 
numbered on the basis of its retention times during the 
separation using liquid chromatography. 
Characterization of by-products in the presence of NaCl
Carbamazepine exhibited a protonated molecular ion 
at m/z 237.0915 (high intensity), and sodium adduct ion at 
m/z 259.0726 (low intensity). Moreover, a minor protonated 
ion was also observed at m/z 194.0872, which resulted from 
cleavage of the CHNO fragment in the ion source. 
Products I and VIII, as derivatives of hydroxy-CBZ, 
were formed in the presence of both NaCl and Na2SO4, 
separately at m/z 253.0857 and 7.71 min. Three main 
ions are fragmented from the source ion at m/z 236.0586, 
210.0816 and 180.0720, which are referring to loss of OH 
group, CONH and C2O2NH2, respectively, as previously 
suggested by Keen et al.8 
The compound marked as II (Figure 4a), whose sodium 
adduct form presented at m/z 309.0248, corresponded 
to a mass increase of 22 Da with respect to protonated 
molecular ion of carbamazepine (m/z 287.0449). The 
empirical formula that matches the experimental mass 
was C15H11ClN2O2 with an error of 0.33 ppm. From the 
mass spectrum, product II is probably chlorinated CBZ. 
The most striking aspects of these spectra are the clusters 
of intense peaks that are each separated by m/z 2 Da. 
However, the isotopic distribution (i.e., presence of an ion 
at m/z 287 (+2 Da) with an abundance of about one-third 
of that molecular ion) indicated that one chlorine atom is 
available in this compound. Two more molecular ions are 
formed at m/z 236.0587 and 180.0711, which could refer 
to loss of NHCl and CO2N, respectively.
Product III is likely to be the product of the cyclation 
amide group producing a molecular ion with high intensity as 
sodium adduct (m/z 245.0661) and the protonated molecular 
ion is m/z 223.0886. The mass spectra is very clear, which 
means no more fragmentations, it may be due to the difficulty 
of the cyclic amide group to give more daughter ions. 
A mono-hydroxy carbamazepine is presented in 
product IV showing a sodium adduct molecular ion at 
m/z 277.0700 (+22 Da) (0.19 ppm) and its protonated 
molecular ion at m/z 255.0896. However, fragment ion was 
detected at m/z 209.0849 (−46 Da), which may refer to the 
loss of H2N2O group. 
Product V, as derivative of diol-CBZ, and product VI, 
as a derivative of chloro-diol-CBZ, have intensity of 
protonated molecular ions [M + H]+ higher than sodium 
adduct molecular ions [M + Na]+ as shown from the mass 
spectra for each one (Figure 4a). However, product V 
gives one mass peak at m/z 232.1575 (−40 Da) referring 
to CNO loss. The mass spectrum of product VI indicated 
a molecular ion at m/z 306.1082. The peaks at m/z 306 and 
308 in Figure 4a, in an approximate of 3:1, indicate that one 
Cl atom is present in this molecular ion. One additional mass 
Figure 3. LC-TOF/MS (TIC 100-500 amu) chromatogram of the 
electrochemical oxidation of carbamazepine: (a) in the presence of NaCl 
and (b) in the presence of N2SO4.
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peak was present in this product at m/z 289.1395 indicating 
OH loss. 
Characterization of by-products via Na2SO4
In the presence of Na2SO4 as supporting electrolyte, 
three products were formed (Figure 4b): product VIII 
(discussed before) and products VII (derivative of diol-
CBZ) and IX (derivative of poly hydroxyl-CBZ). The 
sodium adduct molecular ion is the dominant ion as 
produced at m/z 249.1461 for product VII. This product 
exhibited mass peak at m/z 181.0649 which could refer 
to CO2H loss. Product IX was presented as protonated 
molecular ion at m/z 290.2551 indicating four OH groups 
substituted on CBZ. One mass peak that appeared at 
m/z 274.2621 may refer to loss of one oxygen atom. 
As presented in Scheme 1a, product I was identified 
as hydroxyl-CBZ, which could be produced by attack of 
hydroxyl radical on the double bond of hepta-ring CBZ 
producing product I (C15H12N2O2, 0.21 ppm). This product 
was reported by Keen et al.8 during UV/H2O2 advanced 
oxidation of carbamazepine. Moreover, addition of water 
molecule to the double bond of the hepta-ring resulted in 
alcohol-CBZ, which could be converted to epoxy-CBZ 
(product II) after attacking the amide group by chlorine. 
Mohapatra et al.30 reported that epoxy carbamazepine 
Figure 4. Mass spectra and proposed chemical structures of CBZ and (a) by-products (I-VI) in the presence of NaCl and (b) by-products (VIII-IX) in 
the presence of Na2SO4.
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was formed (m/z 251.1) during Fenton photo oxidation of 
carbamazepine, which is matching to the by-product chloro 
epoxy carbamazepine (m/z 287.0449) (product II) formed 
after electrochemical treatment of carbamazepine in the 
presence of NaCl. However, comparing to the literature, 
this present study is more reliable in terms of proposed 
formation of the by-products.
Products V and VI have been detected as diol-CBZ which 
have been reported by other previous studies.29,31 They are 
produced by the hydrolysis of epoxy-CBZ derivatives. For 
our knowledge, chloro-CBZ products were formed only in 
the presence of NaCl meaning that chlorine is released in the 
NaCl, solution to form OCl−/HOCl as oxidizing agent. In the 
presence of Na2SO4 (Scheme 1b), there is no more production 
of chloro-CBZ. Product VII (diol-CBZ) is formed after 
hydrolysis of product VIII and losing CH2NO moiety from 
its structure. Product VIII was determined after treatment 
of carbamazepine in three different treatment processes: 
ultrasonication, Fenton’s oxidation and ferro-sonication 
treatment process.30 Product IX is formed by opening the 
hepta-ring of CBZ-derivative (product VIII) to form aliphatic 
alcohol chain.
In the light of the above results, the type of treatment 
plays an important role to determine and figure out the 
produced by-product. However, Andreozzi et al.32 reported 
that ozonation of carbamazepine produced glyoxal, oxalic 
acid, oxamic acid, etc., which none of them were formed 
in this present study.
Toxicity vs. by-products
There is a very lack of information in the literature 
on the ecotoxicity of carbamazepine and its by-products, 
thus the assessment of the potential risk derived from their 
presence in the environment is essential. Figure 5 shows 
the evolution of inhibition percentage (I%) of E. coli 
bacteria as a function of electrolysis time in the presence 
of NaCl and Na2SO4 at different incubation time (1.0, 5.0 
and 24.0 h) using a graphite-PVC composite anode. From 
current results concerning NaCl as supporting electrolyte, 
the inhibition percentages of E. coli bacteria increase to 
the maximum values of 90, 70 and 40% within 40-80 min 
at 24.0, 5.0 and 1.0 h, respectively. The inhibition 
percentage is maximum at 80 min for 24.0, 5.0 and 1.0 h 
incubation time, followed by a rapid decrease after 80 min 
indicating a drop in toxicity. Same phenomena occurred 
with Na2SO4 in which the rate of inhibition increased early 
until maximum values of 65, 60 and 43% at 24.0, 5.0 and 
1.0 h, respectively, then steadily dropped after 20 min. Of 
course, the toxicity of CBZ after treatment relates strongly 
to the by-products produced during electrochemical 
oxidation treatment. However, Figure 5a shows the 
appearance and disappearance of the by-products (I, II, 
III, IV, V and VI) which is probably responsible for the 
inhibition of Luminous E. coli bacteria. Product I reached 
early to its maximum at 20 min then rapidly decreased to 
the minimum value. There seems to be no effect on the 
toxicity since the toxicity still increase with decreasing 
product I. Three products (II, IV and VI) are the most 
effective on the inhibition of Luminous E. coli bacteria. 
The highest value of the three products is at 80 min which 
could be responsible for the highest value of the toxicity 
at 80 min. This behavior was also reported by some 
authors for different compounds.33,34 From Figure 5b, 
it was observed that the inhibition of Luminous E. coli 
bacteria was increased to 60% after 20 min of treatment 
Scheme 1. Electrochemical degradation pathway proposed for CBZ 
(a) in the presence of NaCl and (b) in the presence of Na2SO4. 
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and 24.0 h of incubation. The reason may be attributed 
to the formation of three effective products (VII, VIII 
and XI) in the presence of Na2SO4 at the same time of 
treatment, 20 min. This value is still much lower than 
90% (in the presence of NaCl), which could indicate 
formation of non-chlorinated by-products (less toxicity) 
as compared to the chlorinated by-products. From these 
results, NaCl is considered a more suitable electrolyte 
since all by-products disappeared after 140 min compared 
to those formed with Na2SO4 which is still accumulated 
in solution. In contract, the toxicity of the carbamazepine 
and its by-products is almost vanished after 120 min to 
very low value of 15%, which is lower than the initial 
toxicity of original compound of 30%. 
Conclusions
Electrochemical oxidation process of carbamazepine 
in water sample was carried out in this work. The effect 
of various operating parameters such as amount of NaCl, 
initial concentration of carbamazepine, applied voltage 
and treatment time was designed by using 24 full factorial 
design on removal efficiency (%) of CBZ. According 
to the factorial design plots, the most significant factors 
on removal efficiency (%) were applied voltage (C), 
NaCl amount (A) and treatment time (D). However, the 
Figure 5. Evolution of toxicity to E. coli bacteria after 1.0, 5.0 and 24.0 h of exposure (a) in the presence of NaCl and (b) in the presence of Na2SO4. The 
evolution of the by-products during electrochemical degradation of CBZ is depicted in each case. Experimental conditions: [CBZ]0 = 5 mg L-1; 0.2 g NaCl; 
and 0.2 g Na2SO4.
interaction factors AC and CD were also significant. 
Conversely, the other interactions were not more significant 
like ABC, AB and ABD.
The formation of by-products was presented and 
elucidated using very advanced and accurate instrument 
(LC-TOF/MS). Six by-products were analyzed and 
identified correctly in the presence of NaCl while three 
by-products were only analyzed and identified in the 
presence of Na2SO4. Chloro-epoxy carbamazepine was 
identified for the first time after electrochemical treatment 
for carbamazepine. NaCl electrolyte was considered more 
effective compared to Na2SO4 in terms of degradation 
efficiency of CBZ. Hypochlorite OCl− was observed as 
a powerful oxidizing agent to reduce the toxicity of CBZ 
and its by-products. However, in this study the toxicity 
was evaluated at different incubation times (1.0, 5.0 and 
24.0 h) against the by-products which are formed during 
electrochemical oxidation process of carbamazepine. The 
toxicity of the treated carbamazepine solution samples was 
assessed by measuring the inhibition of E. coli bacteria.
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